New from Johns Hopkins Health Alerts–The National Cancer Institute estimates that between 5% and 8% of cancer patients participate in clinical trials. Why is the number so low? Part of the problem is that many patients believe that all clinical trials include a placebo (an inactive treatment with no known therapeutic value) and treat participants like “guinea pigs”–neither of which is true. To help clear up the confusion, this Johns Hopkins Health Alert explains clinical trial terminology, including randomization, placebo, and blinding. Click on the link to read the complete report: http://www.johnshopkinshealthalerts.com/alerts/prostate_disorders/JohnsHopkinsHealthAlertProstateDisorders_3263-1.html?ET=johnshopkins_blog:e34955:607412a:&st=email&st=email&s=EPH_091217_013
Press release: Tuesday, November 10, 2009 11:07 AM
NIH ANNOUNCES FIRST NATIONAL RESEARCH STUDY RECRUITMENT REGISTRY Nationwide Registry to “Match” Volunteers with Researchers Continue Reading…
POSITIVE MENTAL ATTITUDE WALK
- Cancer is the most curable of all chronic diseases.
- There are treatments for every type of cancer. Continue Reading…
The R.A. Bloch Cancer Foundation is always on the lookout for organizations or publications that can help patients and their supporters. We have four to share with you.